Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice

Rajarajan A. Thandavarayan, Kenichi Watanabe, Flori R. Sari, Meilei Ma, Arun Lakshmanan, Vijayasree V. Giridharan, Narasimman Gurusamy, Hiroshi Nishida, Tetsuya Konishi, Shaosong Zhang, Anthony J. Muslin, Makoto Kodama, Yoshifusa Aizawa

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Doxorubicin (Dox) is a widely used antitumor drug, but its application is limited because of its cardiotoxic side effects. Increased expression of p38α mitogen-activated protein kinase (MAPK) promotes cardiomyocyte apoptosis and is associated with cardiac dysfunction induced by prolonged agonist stimulation. However, the role of p38α MAPK is not clear in Dox-induced cardiac injury. Cardiac dysfunction was induced by a single injection of Dox into wild-type (WT) mice and transgenic mice with cardiac-specific expression of a dominant-negative mutant form of p38α MAPK (TG). Left ventricular (LV) fractional shortening and ejection fraction were higher and the expression levels of phospho-p38 MAPK and phospho-MAPK-activated mitogen kinase 2 were significantly suppressed in TG mouse heart compared to WT mice after Dox injection. Production of LV proinflammatory cytokines, cardiomyocyte DNA damage, myocardial apoptosis, caspase-3-positive cells, and phospho-p53 expression were decreased in TG mice after Dox injection. Moreover, LV expression of NADPH oxidase subunits and reactive oxygen species was significantly less in TG mice compared to WT mice after Dox injection. These findings suggest that p38α MAPK may play a role in the regulation of cardiac function, oxidative stress, and inflammatory and apoptotic mediators in the heart after Dox administration.

Original languageEnglish
Pages (from-to)1422-1431
Number of pages10
JournalFree Radical Biology and Medicine
Volume49
Issue number9
DOIs
Publication statusPublished - 1 Nov 2010
Externally publishedYes

Fingerprint

p38 Mitogen-Activated Protein Kinases
Doxorubicin
Modulation
Injections
Cardiac Myocytes
Apoptosis
Oxidative stress
NADPH Oxidase
Mitogen-Activated Protein Kinases
Mitogens
Caspase 3
Antineoplastic Agents
Transgenic Mice
DNA Damage
Reactive Oxygen Species
Oxidative Stress
Phosphotransferases
Cells
Cytokines
DNA

Keywords

  • Apoptosis
  • Doxorubicin
  • Free radicals
  • Oxidative stress
  • P38α MAPK

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. / Thandavarayan, Rajarajan A.; Watanabe, Kenichi; Sari, Flori R.; Ma, Meilei; Lakshmanan, Arun; Giridharan, Vijayasree V.; Gurusamy, Narasimman; Nishida, Hiroshi; Konishi, Tetsuya; Zhang, Shaosong; Muslin, Anthony J.; Kodama, Makoto; Aizawa, Yoshifusa.

In: Free Radical Biology and Medicine, Vol. 49, No. 9, 01.11.2010, p. 1422-1431.

Research output: Contribution to journalArticle

Thandavarayan, RA, Watanabe, K, Sari, FR, Ma, M, Lakshmanan, A, Giridharan, VV, Gurusamy, N, Nishida, H, Konishi, T, Zhang, S, Muslin, AJ, Kodama, M & Aizawa, Y 2010, 'Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice', Free Radical Biology and Medicine, vol. 49, no. 9, pp. 1422-1431. https://doi.org/10.1016/j.freeradbiomed.2010.08.005
Thandavarayan, Rajarajan A. ; Watanabe, Kenichi ; Sari, Flori R. ; Ma, Meilei ; Lakshmanan, Arun ; Giridharan, Vijayasree V. ; Gurusamy, Narasimman ; Nishida, Hiroshi ; Konishi, Tetsuya ; Zhang, Shaosong ; Muslin, Anthony J. ; Kodama, Makoto ; Aizawa, Yoshifusa. / Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. In: Free Radical Biology and Medicine. 2010 ; Vol. 49, No. 9. pp. 1422-1431.
@article{78d023a3eb6644d892867e311f0f2351,
title = "Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice",
abstract = "Doxorubicin (Dox) is a widely used antitumor drug, but its application is limited because of its cardiotoxic side effects. Increased expression of p38α mitogen-activated protein kinase (MAPK) promotes cardiomyocyte apoptosis and is associated with cardiac dysfunction induced by prolonged agonist stimulation. However, the role of p38α MAPK is not clear in Dox-induced cardiac injury. Cardiac dysfunction was induced by a single injection of Dox into wild-type (WT) mice and transgenic mice with cardiac-specific expression of a dominant-negative mutant form of p38α MAPK (TG). Left ventricular (LV) fractional shortening and ejection fraction were higher and the expression levels of phospho-p38 MAPK and phospho-MAPK-activated mitogen kinase 2 were significantly suppressed in TG mouse heart compared to WT mice after Dox injection. Production of LV proinflammatory cytokines, cardiomyocyte DNA damage, myocardial apoptosis, caspase-3-positive cells, and phospho-p53 expression were decreased in TG mice after Dox injection. Moreover, LV expression of NADPH oxidase subunits and reactive oxygen species was significantly less in TG mice compared to WT mice after Dox injection. These findings suggest that p38α MAPK may play a role in the regulation of cardiac function, oxidative stress, and inflammatory and apoptotic mediators in the heart after Dox administration.",
keywords = "Apoptosis, Doxorubicin, Free radicals, Oxidative stress, P38α MAPK",
author = "Thandavarayan, {Rajarajan A.} and Kenichi Watanabe and Sari, {Flori R.} and Meilei Ma and Arun Lakshmanan and Giridharan, {Vijayasree V.} and Narasimman Gurusamy and Hiroshi Nishida and Tetsuya Konishi and Shaosong Zhang and Muslin, {Anthony J.} and Makoto Kodama and Yoshifusa Aizawa",
year = "2010",
month = "11",
day = "1",
doi = "10.1016/j.freeradbiomed.2010.08.005",
language = "English",
volume = "49",
pages = "1422--1431",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice

AU - Thandavarayan, Rajarajan A.

AU - Watanabe, Kenichi

AU - Sari, Flori R.

AU - Ma, Meilei

AU - Lakshmanan, Arun

AU - Giridharan, Vijayasree V.

AU - Gurusamy, Narasimman

AU - Nishida, Hiroshi

AU - Konishi, Tetsuya

AU - Zhang, Shaosong

AU - Muslin, Anthony J.

AU - Kodama, Makoto

AU - Aizawa, Yoshifusa

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Doxorubicin (Dox) is a widely used antitumor drug, but its application is limited because of its cardiotoxic side effects. Increased expression of p38α mitogen-activated protein kinase (MAPK) promotes cardiomyocyte apoptosis and is associated with cardiac dysfunction induced by prolonged agonist stimulation. However, the role of p38α MAPK is not clear in Dox-induced cardiac injury. Cardiac dysfunction was induced by a single injection of Dox into wild-type (WT) mice and transgenic mice with cardiac-specific expression of a dominant-negative mutant form of p38α MAPK (TG). Left ventricular (LV) fractional shortening and ejection fraction were higher and the expression levels of phospho-p38 MAPK and phospho-MAPK-activated mitogen kinase 2 were significantly suppressed in TG mouse heart compared to WT mice after Dox injection. Production of LV proinflammatory cytokines, cardiomyocyte DNA damage, myocardial apoptosis, caspase-3-positive cells, and phospho-p53 expression were decreased in TG mice after Dox injection. Moreover, LV expression of NADPH oxidase subunits and reactive oxygen species was significantly less in TG mice compared to WT mice after Dox injection. These findings suggest that p38α MAPK may play a role in the regulation of cardiac function, oxidative stress, and inflammatory and apoptotic mediators in the heart after Dox administration.

AB - Doxorubicin (Dox) is a widely used antitumor drug, but its application is limited because of its cardiotoxic side effects. Increased expression of p38α mitogen-activated protein kinase (MAPK) promotes cardiomyocyte apoptosis and is associated with cardiac dysfunction induced by prolonged agonist stimulation. However, the role of p38α MAPK is not clear in Dox-induced cardiac injury. Cardiac dysfunction was induced by a single injection of Dox into wild-type (WT) mice and transgenic mice with cardiac-specific expression of a dominant-negative mutant form of p38α MAPK (TG). Left ventricular (LV) fractional shortening and ejection fraction were higher and the expression levels of phospho-p38 MAPK and phospho-MAPK-activated mitogen kinase 2 were significantly suppressed in TG mouse heart compared to WT mice after Dox injection. Production of LV proinflammatory cytokines, cardiomyocyte DNA damage, myocardial apoptosis, caspase-3-positive cells, and phospho-p53 expression were decreased in TG mice after Dox injection. Moreover, LV expression of NADPH oxidase subunits and reactive oxygen species was significantly less in TG mice compared to WT mice after Dox injection. These findings suggest that p38α MAPK may play a role in the regulation of cardiac function, oxidative stress, and inflammatory and apoptotic mediators in the heart after Dox administration.

KW - Apoptosis

KW - Doxorubicin

KW - Free radicals

KW - Oxidative stress

KW - P38α MAPK

UR - http://www.scopus.com/inward/record.url?scp=77957132594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957132594&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2010.08.005

DO - 10.1016/j.freeradbiomed.2010.08.005

M3 - Article

C2 - 20705132

AN - SCOPUS:77957132594

VL - 49

SP - 1422

EP - 1431

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 9

ER -